Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a dedicated Locations section showing Durham, North Carolina (Duke Cancer Center) and updated the page's revision to v3.3.3. Removed the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T13:35:42.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:53.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Deletion of the government funding status notice that could indicate potential delays; this does not alter the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:04:53.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page. The observed changes appear to be routine metadata updates (e.g., last update timestamps) rather than substantive edits to study content.
    Difference
    0.5%
    Check dated 2025-11-03T01:30:08.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-05T10:19:34.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:20:00.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.